Daiwa Securities Group’s Denali Therapeutics DNLI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $7K | Hold |
475
| – | – | ﹤0.01% | 1133 |
|
|
2025
Q1 | $6K | Hold |
475
| – | – | ﹤0.01% | 1121 |
|
|
2024
Q4 | $10K | Sell |
475
-71
| -13% | -$1.5K | ﹤0.01% | 1118 |
|
|
2024
Q3 | $16K | Hold |
546
| – | – | ﹤0.01% | 1110 |
|
|
2024
Q2 | $13K | Hold |
546
| – | – | ﹤0.01% | 1145 |
|
|
2024
Q1 | $11K | Hold |
546
| – | – | ﹤0.01% | 1155 |
|
|
2023
Q4 | $12K | Hold |
546
| – | – | ﹤0.01% | 1152 |
|
|
2023
Q3 | $11K | Hold |
546
| – | – | ﹤0.01% | 1117 |
|
|
2023
Q2 | $16K | Hold |
546
| – | – | ﹤0.01% | 1107 |
|
|
2023
Q1 | $13K | Hold |
546
| – | – | ﹤0.01% | 1086 |
|
|
2022
Q4 | $15K | Buy |
546
+88
| +19% | +$2.42K | ﹤0.01% | 1084 |
|
|
2022
Q3 | $14K | Hold |
458
| – | – | ﹤0.01% | 1104 |
|
|
2022
Q2 | $13K | Buy |
458
+102
| +29% | +$2.9K | ﹤0.01% | 1124 |
|
|
2022
Q1 | $11K | Hold |
356
| – | – | ﹤0.01% | 1129 |
|
|
2021
Q4 | $16K | Sell |
356
-61
| -15% | -$2.74K | ﹤0.01% | 1121 |
|
|
2021
Q3 | $21K | Buy |
417
+177
| +74% | +$8.91K | ﹤0.01% | 1097 |
|
|
2021
Q2 | $19K | Hold |
240
| – | – | ﹤0.01% | 1016 |
|
|
2021
Q1 | $14K | Buy |
240
+14
| +6% | +$817 | ﹤0.01% | 1026 |
|
|
2020
Q4 | $19K | Sell |
226
-361
| -61% | -$30.4K | ﹤0.01% | 983 |
|
|
2020
Q3 | $21K | Hold |
587
| – | – | ﹤0.01% | 975 |
|
|
2020
Q2 | $10K | Hold |
587
| – | – | ﹤0.01% | 1052 |
|
|
2020
Q1 | $10K | Buy |
587
+45
| +8% | +$767 | ﹤0.01% | 1047 |
|
|
2019
Q4 | $9K | Sell |
542
-62
| -10% | -$1.03K | ﹤0.01% | 1062 |
|
|
2019
Q3 | $9K | Hold |
604
| – | – | ﹤0.01% | 1026 |
|
|
2019
Q2 | $13K | Hold |
604
| – | – | ﹤0.01% | 1027 |
|
|
2019
Q1 | $14K | Sell |
604
-161
| -21% | -$3.73K | ﹤0.01% | 999 |
|
|
2018
Q4 | $16K | Buy |
+765
| New | +$16K | ﹤0.01% | 968 |
|